Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Cited by (1,000)

Items 901–1,000 of 1,000

1. SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case–Control Study
   Kei Moriya, Tomoko Nakakita, Natsuki Nakayama, Yuya Matsuo, Yusuke Komeda, Junichi Hanatani, Daisuke Kaya, Shinsaku Nagamatsu, Hideki Matsuo, Masakazu Uejima et al. · 2023 · Journal of Clinical Medicine
2. Immune response, phenotyping and molecular graft surveillance in kidney transplant recipients following severe acute respiratory syndrome coronavirus 2 vaccination
   Nicole M Ali, Ramin S. Herati, Sapna A Mehta, Jeanette Leonard, Jake Miles, Bonnie E. Lonze, Charles J. DiMaggio, Vasishta Tatapudi, Zoe A. Stewart, Nasser M. Alnazari et al. · 2023 · Transplant Infectious Disease
3. Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study
   Sitthichai Kanokudom, Nungruthai Suntronwong, Thaneeya Duangchinda, Nasamon Wanlapakorn, Yong Poovorawan · 2023 · Cureus
4. Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients
   Eunice Xiang Xuan Tan, Wen Hui Lim, Elizabeth H. Thong, Jean‐Marc Chavatte, Jinyan Zhang, Jonathan Lim, Jocelyn Y. Jin, Daniel R X Lim, Jaclyn Y.T. Kang, Ansel Shao Pin Tang et al. · 2023 · Transplantation Direct
5. Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII)
   Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, Belén Beltrán, Eugeni Domènech, Ana Gutiérrez, Míriam Mañosa, Yamile Zabana, Lourdes Roc Alfaro, Emilio Valverde Romero et al. · 2024 · Gastroenterología y Hepatología
6. Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective
   Radha Ambalavanan, R Sterling Snead, Julia Marczika, Alex Malioukis · 2024 · Frontiers in Public Health
7. Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers
   E. A. Medvedeva, Kirill Alekseevich Zykov, Herman G. Marin, Антонина Александровна Плоскирева, О. А. Свитич, Alla Nikolaevna Kaira, Д. А. Назаров, Волынков Игорь Олегович, Alexander A. Kuzin, Anatoly Vladimirovich Kubyshkin et al. · 2024 · Annals of the Russian academy of medical sciences
8. Immunological Insights: A Multicenter Longitudinal Study on Humoral Response to COVID-19 Vaccines in Greece
   Eleni Makrì, Ekatherina Charvalos, Elisavet Stavropoulou, Constantina Skanavis, Areti Lagiou, Anastasia Barbounis · 2024 · Acta Microbiologica Hellenica
9. Serological responses to COVID-19 vaccination in patients with chronic liver diseases
   Yu‐Shan Huang, Szu‐Min Hsieh, Feng‐Chiao Tsai, Chien‐Chih Tung, Hung‐Chih Yang, Sui‐Yuan Chang, Jann‐Tay Wang, Chun‐Jen Liu, Tung‐Hung Su, Jia‐Horng Kao · 2024 · Journal of the Formosan Medical Association
10. Tailoring COVID-19 Vaccination Strategies in High-Seroprevalence Settings: Insights from Ethiopia
    Esayas Kebede Gudina, Kira Elsbernd, Daniel Yilma, Rebecca Kisch, Karina Wallrafen-Sam, Gemeda Abebe, Zeleke Mekonnen, Melkamu Berhane, Mulusew J. Gerbaba, Sultan Suleman et al. · 2024 · Vaccines
11. Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
    Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan Fan‐Ngai Hung, Wai‐Kay Seto, Man‐Fung Yuen, Ka Shing Cheung · 2024 · Journal of Gastroenterology and Hepatology
12. Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
    Edmund G. Wee, Sarah L. Kempster, Deborah Ferguson, Joanna Hall, Claire Ham, Susan Jane Morris, Alison Crook, Sarah C. Gilbert, Bette Korber, Neil M. Almond et al. · 2024 · Vaccines
13. Robust immune response to COVID-19 vaccination in the island population of Greenland
    Mie Møller, Lennart Jan Friis-Hansen, Nikolai Soren Kirkby, Christine Dilling-Hansen, Mikael Andersson, Peter Vedsted, Kåre Mølbak, Anders Koch · 2024 · Communications Medicine
14. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
    Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, Belén Beltrán, Eugeni Domènech, Ana Gutiérrez Casbas, Míriam Mañosa, Yamile Zabana, Lourdes Roc Alfaro, Emilio Valverde Romero et al. · 2024 · Gastroenterología y Hepatología (English Edition)
15. Durability of SARS-CoV-2 IgG response: a cross-sectional study in vaccinated healthcare workers using dried blood spot and multi-antigen profiling
    Imam Nurjaya, Erwin Arief, Nur Ahmad Tabri, Irawaty Djaharuddin, Bulkis Natsir, Sitti Nurisyah, Joko Hendarto, Ansariadi Ansariadi, Rasiha Rasiha, Moh Anfasa Giffari Makkaraka · 2024 · Exploration of Immunology
16. Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study
    Yves Dimitrov, Thierry Krummel, François Chantrel, Françoise Heibel, Marc Kribs, Thierry P. Hannedouche · 2024 · BMC Nephrology
17. Antibody Responses and Infection Prevention Following the Sixth Vaccination Using the BA.1 Bivalent COVID-19 Vaccine Among Healthcare Workers During the XBB Variant Dominance in Japan
    Misuzu Yahaba, Haruna Asano, Kengo Saito, Shota Murata, Kenji Kawasaki, Hitoshi Chiba, Shou Yokota, Hiroshi Yoshikawa, Yoriko Herai, Kazutaka Yamagishi et al. · 2024 · Japanese Journal of Infectious Diseases
18. Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron period
    Shilpa Vasishta, Judith A. Aberg, Gopi Patel, Pooja Anand Gownivaripally, Meenakshi M. Rana · 2025 · Therapeutic Advances in Infectious Disease
19. Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients
    Yana Debie, Irene Garcia-Fogeda, Lander Willem, Ella Roelant, Lise Verbruggen, Greetje Vanhoutte, Lieselot Croes, Christof Vulsteke, Wim Demey, Willem Lybaert et al. · 2025 · Scientific Reports
20. Serological Correlate of Protection Established by Neutralizing Antibodies Differs Among Dialysis Patients with SARS-CoV-2 Variants of Concern
    Guy Rostoker, Stéphanie Rouanet, Myriam Merzoug, Hiba Chakaroun, Mireille Griuncelli, Christelle Loridon, Ghada Boulahia, Luc Gagnon · 2025 · Vaccines
21. The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response
    Franz Mai, Emil Christian Reisinger, Brigitte Müller‐Hilke · 2025 · Clinical Immunology
22. Persistence of a High Seroconversion Rate 3.2 ± 0.13 Years After Last COVID‐19 Vaccination in Heart Transplant Recipients
    Robin Arcani, Pı̈erre Ambrosi · 2025 · Clinical Transplantation
23. Conversion Factors to Compare Serum Concentrations of Anti-HBs, Anti-SARS-CoV-2 and Anti-Tetanus Toxin IgG
    Aurelia Knispel, Christian Jassoy · 2025 · Antibodies
24. A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era
    Sean C. Taylor · 2021 · Journal of Clinical Virology Plus
25. SARS CoV-2-Immunität – Stärken und Schwächen
    Tim Niehues · 2021 · DMW - Deutsche Medizinische Wochenschrift
26. Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients
    Waël El Haggan, Bruno Berdin, M. El Salhy · 2022 · Clinical Kidney Journal
27. Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
    Simon Ronicke, Bilgin Osmanodja, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Bianca Zukunft, Friederike Bachmann, Mira Choi, U. Weber et al. · 2022 · Journal of Clinical Medicine
28. Evaluating Correlates of Protection for Mix-Match Vaccine Against COVID-19 VOCs With Potential of Evading Immunity
    Sih‐Han Liao, Wei‐Jung Chang, Chen‐Yang Hsu, Amy Ming‐Fang Yen, Ting-Yu Lin, Sam Li‐Sheng Chen, Tony Hsiu-Hsi Chen · 2022 · Vaccine
29. The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study
    Allen Widysanto, Ignatius Bima Prasetya, Tandry Meriyanti, Veli Sungono, Diane Lukito Setiawan, Edy Gunawan, Bayu Adiputra, Jane Olivia Lorens, Theresia Santi, Cindy Meidy Leony Pradhana et al. · 2022 · Infectious Medicine
30. Longitudinal serologic and viral testing post–SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort—Georgia, October 2020‒April 2021
    Farrell A. Tobolowsky, Michelle A. Waltenburg, Erin D. Moritz, Melia Haile, Juliana C. DaSilva, Amy J. Schuh, Natalie J. Thornburg, Adrianna Lynn Westbrook, Susannah L. McKay, Stephen P. LaVoie et al. · 2022 · PLoS ONE
31. Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
    Szu-Ting Huang, Yu‐Shan Huang, Wang-Da Liu, Sung‐Ching Pan, Hsin‐Yun Sun, Chia-En Lien, Charles Chen, Szu‐Min Hsieh · 2023 · Journal of the Formosan Medical Association
32. Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers
    Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Satoko Kondo, Kei Gondo, Naoko Fujiyoshi, Junya Minami, Yukiko Harada, Sukehisa Nagano, Takahiko Horiuchi et al. · 2023 · Vaccine
33. Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
    David Hakimian, Johnny Amer, Alaa Jammal, Asher Shafrir, Yael Milgrom, Mohammad Masarowah, Wadi Hazou, Yuval Ishay, Ashraf Imam, Adi Francis et al. · 2023 · Vaccine X
34. Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial
    Laurie Spehner, Émeline Orillard, Antoine Falcoz, Quentin Lepiller, Adeline Bouard, Hamadi Almotlak, Stefano Chong Hun Kim, Elsa Curtit, Guillaume Meynard, Marine Jary et al. · 2023 · BMJ Oncology
35. Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 Vaccine
    Kerri Basile, Jessica E. Agius, Winkie Fong, Kenneth A McPhie, Danny Ko, Linda Hueston, Connie Lam, David Pham, Wen Chen, Susan Maddocks et al. · 2025 · Viruses
36. Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blind, Randomised, Placebo-Controlled Phase 2 Trial
    2021 · TUScholarShare (Temple University)
37. A simple, sensitive and quantitative FACS-based test for SARS-CoV-2 serology in humans and animals
    Agnès Maurel Ribes, Pierre Bessière, Jean‐Charles Guéry, Eloïse Joly Featherstone, Timothée Bruel, Rémy Robinot, Olivier Schwartz, Romain Volmer, Florence Abravanel, Jacques Izopet et al. · 2021 · medRxiv
38. Predicting the Effectiveness of Covid-19 Vaccines from SARS-CoV-2 Variants Neutralisation Data
    Oleg Volkov, Svetlana Borozdenkova, Alexander Gray · 2021 · medRxiv
39. Assessing Immunity by Quantitative Measurement of SARS-CoV-2 IgG Antibodies in Fingerstick Samples
    Javier T. Garza, Jacob Quick, Dev Kumar Chatterjee, R. Patrick Garr, Atul Varadhachary, Leo Linbeck · 2021 · medRxiv
40. Safety and Immunogenicity of Heterologous Boost Immunisation With an Aerosolized Ad5-nCoV After Two-Dose Priming With an Inactivated SARS-CoV-2 Vaccine CoronaVac in Adults: A Randomised, Open-Label, Parallel-Control Trial
    Jingxin Li, Shipo Wu, Xiling Guo, Rong Tang, Baoying Huang, Xiaoqin Chen, Hai-Tao Huang, Yin Chen, Lihua Hou, Jin-Bo Gou et al. · 2022 · SSRN Electronic Journal
41. Waning of SARS-CoV-2 Antibody levels response to inactivated cellular vaccine over 6 months among healthcare workers
    Mônica Taminato, Ana Paula Cunha Chaves, Richarlisson Borges de Morais, Luiz Vinícius Leão Moreira, D. Conte, Klinger Soares Faíco-Filho, Maria Cristina Gabrielloni, Eduardo Alexandrino Medeiros, Nancy Bellei · 2022 · medRxiv
42. Immune responses after twofold SARS-CoV-2 immunisation in elderly residents and Health Care Workers in nursing homes and homes with assisted living support - Proposal for a correlate of protection
    Julia Schiffner, Nora Eisemann, Hannah Baltus, Sina Jensen, Katharina Wunderlich, Stefan Schuesseler, Charlotte Eicker, Bianca Teegen, Doreen Boniakowsky, Werner Solbach et al. · 2022 · medRxiv
43. A Southeast Asia Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2
    Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan‐Chang Chiu, Dung DO-VAN, Masliyana Husin, Kao‐Pin Hwang, Sasisopin Kiertiburanakul, Prasad Suryakant Kulkarni et al. · 2022 · Research Square
44. Pivotal Immune-Bridging Study of the Inactivated Whole-Virus COVID-19 Vaccine VLA2001: A Phase 3, Randomized Controlled Clinical Trial in Adults Using Adenoviral Vector Vaccine AZD1222 as a Comparator
    Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, Juan Carlos Jaramillo, Katrin L. Dubischar, Michael Krammer, Petronela Weisova, Romana Hochreiter, Susanne Eder-Lingelbach, Christian Taucher et al. · 2022 · SSRN Electronic Journal
45. Interrupting methotrexate to improve immunity after COVID-19 booster vaccination: is it really worth it?
    Anselm Jorda, Markus Alexander Zeitlinger · 2022 · The Lancet Respiratory Medicine
46. Effectiveness of SARS‐CoV‐2 vaccines used in Malaysia: A systematic review and meta‐analysis
    Anita Devi Krishnan Thantry, Palaniappan A/L Palaniappan Lakshmanan, Dhanraaj A L Kunasakaran, Edwin Cheah Shenq · 2023 · Research Square
47. Preexposure Prophylaxis against COVID-19 with Tixagevimab/Cilgavimab in Slovenian National Cohort of Kidney Transplant Recipients
    Špela Borštnar, Miha Arnol, Željka Večerić Haler, Gregor Mlinšek · 2023 · Preprints.org
48. Humoral immune response to omicron infection in long-term Wuhan-Hu-1-imprinted population
    Yingying Lü, Yufang Zhu, Yulan Zheng, Lu Tang, Hui Chen, Cai-Li Zhou, Jiayuan Luo, Xuejiao Yang, Lu Yu, Qiyan Hu et al. · 2023 · Research Square
49. Immune Responses Following Administration of Whole Gamma Irradiated SARS-CoV-2 Vaccine Stabilized With Disaccharide Trehalose on Syrian Hamster Model
    Farahnaz Motamedi-Sedeh, Akbar Khorasani, Mohsen Lotfi, Seyed Morteza Moosavi, Arash Arbabi, Seyed Maede Hosseini · 2023 · Research Square
50. Hybrid, Vaccine-Induced and Natural Immunity Against SARS-CoV-2 in Traditional Food Markets in Bolivia (2020-2022): A Cross-Sectional Analysis of a Serological Survey
    Christine Leyns, Elliot McClenaghan, Patricia Rodríguez, Patrick Nguipdop‐Djomo, Carla Ascarrunz, Daniel Eid Rodríguez, Punam Mangtani, Javier Guitián · 2024 · SSRN Electronic Journal
51. Bivalent mRNA booster encoding virus-like particles elicits potent polyclass receptor-binding domain antibodies in pre-vaccinated mice
    Chengcheng Fan, Alexander A. Cohen, Kim-Marie A. Dam, Annie V. Rorick, Ange-Célia I Priso Fils, Zhi Yang, Priyanthi N.P. Gnanapragasam, Luisa N. Segovia, Kathryn E. Huey‐Tubman, Woohyun J Moon et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
52. Bivalent mRNA booster encoding virus-like particles elicits potent polyclass receptor-binding domain antibodies in pre-vaccinated mice
    Chengcheng Fan, Alexander A. Cohen, Kim-Marie A. Dam, Annie V. Rorick, Ange-Célia I Priso Fils, Zhi Yang, Priyanthi N.P. Gnanapragasam, Luisa N Segovia, Kathryn E. Huey‐Tubman, Woohyun J Moon et al. · 2025 · eLife
53. Influences impacting on parent involvement in an inner-city elementary school.
    Frances Gamer · 2023 · ScholarWorks@UMassAmherst (University of Massachusetts Amherst)
54. Serologic survey for toxoplasmosis in bats: a preliminary study in Brazil.
    Felipe Fornazari, Hélio Langoni, Josef Köfer, Hermann Schobesberger · 2011
55. Twelve-Month Follow-up of Early COVID-19 Cases in the United States: Cellular and Humoral Immune Longevity
    Melisa M. Shah, Mohammad Ata Ur Rasheed, Jennifer L. Harcourt, Glen R. Abedi, Megan M. Stumpf, Hannah L. Kirking, Azaibi Tamin, Lisa A. Mills, Madeleine Armstrong, Phillip P. Salvatore et al. · 2022 · Open Forum Infectious Diseases
56. Poor Antibody Responses to SARS-CoV-2 Infection or Vaccination Are Associated With High Re-Infection Rates in Haemodialysis and Renal Transplant Patients
    Sushma Shankar, Joseph G. Beckett, Tom Tipton, Ane Ogbe, Mwila Kasanyinga, Christina Dold, Sheila Lumley, Fungai Dengu, Gianluca Rompianesi, Faysal Elgilani et al. · 2021 · SSRN Electronic Journal
57. Criteria for judging the immune markers of COVID‐19 disease vaccines
    Nan Lin, Haoxuan Fu, Dan Pu, Yuxin Quan, Yueyi Li, Xiaomeng Yin, Yuhao Wei, Hang Wang, Xuelei Ma, Xiawei Wei · 2021 · MedComm
58. Vaccination Induces Stronger Spike Immunity and Better Protection Against SARS-CoV-2 Infection in COVID-19 Recovered Subjects than in Naïve Individuals
    Nicolas Guibert, Carla Saade, Karen Brengel‐Pesce, Mad‐Hélénie Elsensohn, Bruno Pozzetto, Christelle Compagnon, Véronique Barateau, Natacha Mariano, Julie Chaix, Sophia Djebali et al. · 2022 · SSRN Electronic Journal
59. Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2
    Nungruthai Suntronwong, Ritthideach Yorsaeng, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Suvichada Assawakosri, Pornjarim Nilyanimit, Donchida Srimuan, Thaksaporn Thatsanatorn et al. · 2022 · medRxiv
60. Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
    Justin Conklin, Jennifer Minieri Arroyo, Rajnish Kumar, Sai A. Patibandla · 2022 · Clinical Biochemistry
61. Longitudinal monitoring of SARS-CoV-2 neutralizing antibody titers and its impact on employee personal wellness decisions
    Rianna Vandergaast, Timothy S. Carey, Lukkana Suksanpaisan, Chase Lathrum, Riya Narjari, Michelle Haselton, Luke Schnebeck, Aroshi Wijesekara, Andrew Duncan, Luke Russell et al. · 2022 · medRxiv
62. A Southeast Asia Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2
    Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan‐Chang Chiu, Dung DO-VAN, Masliyana Husin, Kao‐Pin Hwang, Sasisopin Kiertiburanakul, Prasad Suryakant Kulkarni et al. · 2022 · Research Square
63. Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent Vaccines
    Evan J. Anderson, Lisa A. Jackson, Nadine Rouphael, Alicia T. Widge, David C. Montefiori, Nicole A. Doria‐Rose, Mehul S. Suthar, Kristen W. Cohen, Sarah E. O’Connell, Mat Makowski et al. · 2022 · Research Square
64. Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies
    Subhash Thuluva, Vikram M. Paradkar, Kishore Turaga, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad R. Medigeshi, Janmejay Singh et al. · 2022 · SSRN Electronic Journal
65. Assessment of the humoral immunity induced by Sputnik V Covid-19 vaccine (GAM-COVID-VAC) in healthcare workers
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas (English Edition)
66. Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
    Gian Luca Salvagno, Brandon Michael Henry, Giuseppe Lippi · 2022 · Infectious Diseases Now
67. Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
    Tristan de Nattes, Sophie Candon, Véronique Lemee, Charlotte Laurent, Dominique Guerrot, Dominique Bertrand · 2022 · Clinical Kidney Journal
68. Application and Historical Aspects of Vaccine Development for Human Healthcare
    Jitendra Malviya, Prince Giri, Balram Rathore, Rishabh Suryawanshi, Aakash Jain, Preeti Chincholikar, Dhanya Mary Koshy · 2022 · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences
69. Impact of HLA divergence on humoral response to SARS-CoV-2 and HBV vaccines in the liver transplantation setting
    Cyrille Féray, Vincent Allain, Jean‐Luc Taupin, Bruno Roche, Christophe Desterke, Ilias Kounis, Zeynep Demir, Anne‐Marie Roque‐Afonso, Audrey Coilly, Didier Samuel et al. · 2022 · medRxiv
70. Booster doses of COVID-19 vaccine: Rationales, implications and way forward for African countries
    Seyi Samson Enitan · 2022 · Innovative Journal of Medical Sciences
71. Changes Over Time in COVID-19 Incidence, Vaccinations, Serum Spike IgG, and Viral Neutralizing Potential Among Individuals From a North American Gaming Venue
    Adam V. Wisnewski, Linda F. Cantley, Julian Campillo Luna, Jian Liu, Richard Smith, Kelly Hager, Carrie A. Redlich · 2022 · Journal of Occupational and Environmental Medicine
72. Impact of ABO Compatibility/Incompatibility on the Perioperative Anti-SARS-CoV-2 Immunoglobulin G Levels in 2 Preoperatively Vaccinated Patients Undergoing Kidney Transplant: A Case Report
    Masatoshi Matsunami, Tomo Suzuki, Shinnosuke Sugihara, Takumi Toishi, Atsuro Kawaji, Kanako Nagaoka, Atsuhiko Ochi, Jun Yashima, Hiroshi Kuji, Kosei Matsue · 2022 · Transplantation Proceedings
73. Sérologie Sars-CoV-2 spike, gadget ou réelle utilité ?
    Carole Émile · 2022 · Option/Bio
74. Preliminary report: Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, KD-414, in healthy adult participants: a non-randomized, open-label phase 2/3 clinical study in Japan
    Keishi Kido, Kayo Ibaragi, Mitsuyoshi Tanishima, Yosuke Muramoto, Shun Nakayama, Kohei Ata, Kenshi Hayashida, Hideki Nakamura, Yasuhiko Shinmura, Yoshiaki Oda et al. · 2022 · medRxiv
75. Humoral response after a fourth “booster” dose of coronavirus disease 2019 vaccination and outcome of Japan's seventh wave of coronavirus disease 2019 infections in hemodialysis patients: A single‐center experience
    Masatoshi Matsunami, Tomo Suzuki, Hiroshi Kuji · 2022 · Therapeutic Apheresis and Dialysis
76. Prediction of Covid-19 vaccine effectiveness in adult populations and in clinically-vulnerable subgroups
    Oleg Volkov, Svetlana Borozdenkova, Alexander Gray · 2022 · medRxiv
77. Assessment of the levels of antispike SARS-CoV-2 IgG antibodies and their association with clinical characteristics in cohort of patients in Saudi Arabia
    Nayef S. AlGannas, Abdullah Alghamdi, AliM Hazazi, Nasser S. Alqahtani, Mohammad N. Alshareef, Mohamed H. Ahmed, Abubakr A. M. Omer, Abdulmajid A. AlShehah · 2022 · Journal of Family Medicine and Primary Care
78. COVID‐19: Immunology
    Yasaswi V. Vengalasetti, Niyousha Naderi, Christian Vega, Akhılesh Kumar, Andrew T. Catanzaro · 2022 · Wiley eBooks
79. Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases
    Parichat Uea‐Areewongsa, Nawamin Pinpathomrat, Jomkwan Ongarj, Ratchanon Sophonmanee, Purilap Seepathomnarong, Bunya Seeyankem, Smonrapat Surasombatpattana, Porntip Intapiboon · 2023 · Asian Pacific Journal of Allergy and Immunology
80. Bölgemizde Uygulanan Biontech ve Sinovac Aşılarına Karşı Gelişen Antikor Yanıtının Değerlendirilmesi
    Kaan Çeylan, Tekin Karslığil, Feyza Nur Aşkın, Gülsüm Kaya Özen · 2023 · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
81. The Role of IL-6 in Inner Ear Impairment: Evidence from 146 Recovered Patients with Omicron Infected in Tianjin, China
    Yu Chen, Xiang Mao, Manbao Kuang, Ziyue Zhang, Mingyu Bo, Yijing Yang, Peng Lin, Wei Wang, Zhongyang Shen · 2023 · Journal of Clinical Medicine
82. Importance of SARS-CoV-2 Spike Antibodies and B Cell Reconstitution to Optimize the Prevention Strategy of COVID-19
    M. Thomas, Jérôme Avouac · 2023 · The Journal of Rheumatology
83. Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals
    Deepika Gujjarlapudi, Adarsh Singamsetty, Sadhana Yelamanchili, Srihita Mahavadi, Namburu Veeraiah, D. Nageshwar Reddy · 2023 · Journal of Laboratory Physicians
84. Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies
    Ha Nui Kim, Jung Hee Yoon, Woong Sik Jang, Chae Seung Lim · 2023 · Diagnostics
85. Assessment of humoral immunity to SARS-CoV-2 by a sample examination of medical workers in a large specialized multidisciplinary hospital
    Alyona A. Murzina, Olga V. Borisova, I. B. Kal’nin, E. A. Medvedeva, German G. Marin, Alla Nikolaevna Kaira · 2023 · Journal of microbiology epidemiology immunobiology
86. Decision letter: Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
    2022 · eLife
87. Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design
    Yen‐Tsung Huang, Jih‐Chang Yu, Jui‐Hsiang Lin · 2023 · The Annals of Applied Statistics
88. Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
    Takeshi Mochizuki, Takaki Hori, Koichiro Yano, Katsunori Ikari, Ken Okazaki · 2023 · Clinical and Experimental Vaccine Research
89. ANTIBODY IgG LEVELS AND ADVERSE EVENTS FOLLOWING IMMUNIZATION AFTER THIRD DOSE OF MODERNA VACCINE IN HEALTHWORKERS AFTER TWO DOSES OF SINOVAC VACCINE
    Ade Tiur Rumondang, Utari Hartati Suryani, Debie Rizqoh, Mardhatillah Sariyanti, Besly Sinuhaji · 2023 · Jurnal Kedokteran dan Kesehatan Publikasi Ilmiah Fakultas Kedokteran Universitas Sriwijaya
90. Waning immune response to CoronaVac in health care workers from different age groups
    Mônica Taminato, Ana Paula Cunha Chaves, Richarlisson Borges de Morais, D. Conte, Maria Cristina Gabrielloni, Gabriela Rodrigues Barbosa, Eduardo Alexandrino Medeiros, Nancy Bellei · 2023 · Revista Brasileira de Medicina do Trabalho
91. Efficacy of COVID-19 Vaccines against Mortality among COVID-19 Cases of Indore, Central India
    Deepak Bansal, Sanjay Avashia, Salil Bhargava, Ketan Jha · 2023 · Indian Journal of Respiratory Care
92. Exposure factors associated with SARS-CoV-2 seropositivity are not predictive for higher humoral immune responses: A cross-sectional cohort study in the general population
    Daniëlle A. T. Hanssen, Demi M. E. Pagen, John Penders, Stephanie Brinkhues, Nicole H. T. M. Dukers–Muijrers, Christian J. P. A. Hoebe, Paul H. M. Savelkoul, Inge H. M. van Loo · 2023 · Journal of Clinical Virology Plus
93. New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses
    Hyunhye Kang, Eun‐Jee Oh · 2023 · Annals of Laboratory Medicine
94. การศกษาการตอบสนองทางภมคมกนของวคซนโรคโควด-19 ชนดเขมกระตนบเอนท16บ2 ในผปวยปลกถายไตทไดรบวคซนโรคโควดชนดแชดดอกซ-1 มาแลว 2 เขม
    ศุภพิชญา ภิรมย์ · 2022
95. Dynamics of immunity over time: decline of anti-SARS-CoV-2 IgG antibodies and T-cell responses after mRNA vaccination in residents and health care workers in nursing homes and homes with assisted living support
    Julia Schiffner, Nora Eisemann, Hannah Baltus, Sina Jensen, Katharina Wunderlich, Stefan Schuesseler, Charlotte Eicker, Bianca Teegen, Doreen Boniakowsky, Werner Solbach et al. · 2023 · PubMed Central
96. Evolution of humoral immune response to SARS-CoV-2 mRNA vaccine in liver transplant recipients – a longitudinal study
    Isabella C Schoepf, Carlotta Riebensahm, Chiara Becchetti, Valentine Blaser, Céline V. Unternährer, Vanessa Martine Banz, Cédric Hirzel, Franziska Suter‐Riniker, Annalisa Berzigotti · 2023 · Swiss Medical Weekly
97. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
    Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, Belén Beltrán, Eugeni Domènech, Ana Gutiérrez, Míriam Mañosa, Yamile Zabana, Lourdes Roc Alfaro, Emilio Valverde Romero et al. · 2023 · Gastroenterología y Hepatología
98. Safety and Efficacy of Tixagevimab and Cilgavimab for Prophylaxis of Covid-19 in a Cohort of Immunosuppressed Rheumatic Patients Treated with Rituximab: A Real-Life Experience
    Silvia Peretti, Francesco Bonomi, Elisa Fiorentini, Francesca Bartoli, Gemma Lepri, Silvia Bellando-Randone, Serena Guiducci · 2023 · Preprints.org
99. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
    Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, Elitza S. Theel, Andreas Wieser · 2023 · Frontiers in Public Health
100. An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5
     Stephen A. Varvel, Marzena M. Galdzicka, Stephanie Nystrom, Hong Liu, Ge Chen, Izabela K. Ragan, Shahrokh Shabahang · 2024 · Frontiers in Immunology